Gerhard Müller-Newen focuses on Cell biology, Immunology, Signal transduction, Cytokine and Cancer research. His studies deal with areas such as Transcription factor and Pathology as well as Cell biology. His Janus kinase study combines topics in areas such as STAT3, SOCS3 and JAK-STAT signaling pathway.
His research integrates issues of Janus kinase 1, Glycoprotein 130 and STAT protein in his study of JAK-STAT signaling pathway. His biological study deals with issues like Leukemia inhibitory factor, which deal with fields such as Suppressor of cytokine signalling and Tyrosine kinase 2. Gerhard Müller-Newen works mostly in the field of Suppressor of cytokine signalling, limiting it down to topics relating to Receptor tyrosine kinase and, in certain cases, Molecular biology, as a part of the same area of interest.
Gerhard Müller-Newen spends much of his time researching Cell biology, Glycoprotein 130, Molecular biology, Receptor and Signal transduction. As part of the same scientific family, he usually focuses on Cell biology, concentrating on Transcription factor and intersecting with Mutant, Nuclear export signal and Inflammation. His Glycoprotein 130 study combines topics from a wide range of disciplines, such as Oncostatin M and Leukemia inhibitory factor receptor, Leukemia inhibitory factor.
His work in Molecular biology covers topics such as Interleukin 6 which are related to areas like Tumor necrosis factor alpha. Gerhard Müller-Newen combines subjects such as Endocrinology, COS cells and Fusion protein with his study of Receptor. As a part of the same scientific study, Gerhard Müller-Newen usually deals with the Janus kinase, concentrating on JAK-STAT signaling pathway and frequently concerns with Tyrosine kinase 2 and SOCS3.
His primary areas of study are Cell biology, Cancer research, STAT3, Transcription factor and Immunology. Gerhard Müller-Newen interconnects Ribosome and Induced pluripotent stem cell in the investigation of issues within Cell biology. His Cancer research study integrates concerns from other disciplines, such as Myeloid Progenitor Cells, Stem cell, Over expression, Kinase and GLI1.
The Transcription factor study combines topics in areas such as Molecular biology, SH2 domain, STAT5, Phosphorylation and STAT protein. His Molecular biology study incorporates themes from Interleukin 6 and Monoclonal antibody. His work on Proinflammatory cytokine and Cytokine as part of his general Immunology study is frequently connected to Hypereosinophilia and Ulcerative colitis, thereby bridging the divide between different branches of science.
His primary areas of investigation include Cell biology, Cancer research, Immunology, Oncostatin M and Tumor necrosis factor alpha. His Cell biology research incorporates themes from RNA and RRNA processing. The various areas that Gerhard Müller-Newen examines in his Cancer research study include Haematopoiesis, Cell cycle, Cyclin E1, Cyclin and Kinase.
His Oncostatin M research includes elements of Colitis and Pathology. The concepts of his Tumor necrosis factor alpha study are interwoven with issues in Proinflammatory cytokine and Interleukin 6. His studies in Signal transduction integrate themes in fields like Inflammation, Molecular biology and Transcription factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
Peter C Heinrich;Iris Behrmann;Serge Haan;Heike M Hermanns.
Biochemical Journal (2003)
INTERLEUKIN-6-TYPE CYTOKINE SIGNALLING THROUGH THE GP130/JAK/STAT PATHWAY
Peter C. Heinrich;Iris Behrmann;Gerhard Müller-Newen;Fred Schaper.
Biochemical Journal (1998)
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease
N R West;A N Hegazy;Owens Bmj.;S J Bullers.
Nature Medicine (2017)
Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies
Karsten Haug;Maike Warnstedt;Alexi K Alekov;Thomas Sander.
Nature Genetics (2003)
Activation of STAT3 by IL-6 and IL-10 in Primary Human Macrophages Is Differentially Modulated by Suppressor of Cytokine Signaling 3
Claudia Niemand;Ariane Nimmesgern;Serge Haan;Patrick Fischer.
Journal of Immunology (2003)
Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
Uta Kunter;Song Rong;Zivka Djuric;Peter Boor.
Journal of The American Society of Nephrology (2006)
Plasticity and cross-talk of interleukin 6-type cytokines.
Christoph Garbers;Heike M. Hermanns;Fred Schaper;Gerhard Müller-Newen.
Cytokine & Growth Factor Reviews (2012)
Mesenchymal Stem Cells Prevent Progressive Experimental Renal Failure but Maldifferentiate into Glomerular Adipocytes
Uta Kunter;Song Rong;Peter Boor;Frank Eitner.
Journal of The American Society of Nephrology (2007)
Identification and Functional Characterization of Dendritic Cells in the Healthy Murine Kidney and in Experimental Glomerulonephritis
Thilo Krüger;Dirk Benke;Frank Eitner;Andreas Lang.
Journal of The American Society of Nephrology (2004)
Soluble IL-6 Receptor Potentiates the Antagonistic Activity of Soluble gp130 on IL-6 Responses
Gerhard Müller-Newen;Andrea Küster;Ulrike Hemmann;Radovan Keul.
Journal of Immunology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Freiburg
Otto-von-Guericke University Magdeburg
Kiel University
Grenoble Alpes University
RWTH Aachen University
University of Luxembourg
RWTH Aachen University
RWTH Aachen University
University of Turin
Forschungszentrum Jülich
Chinese University of Hong Kong, Shenzhen
Paris Dauphine University
University of Virginia
Endor Labs
Qualcomm (United States)
Michigan State University
Carnegie Mellon University
University of Adelaide
National Research Council (CNR)
Georgia Institute of Technology
Brown University
University of Southern California
Scripps Health
Stanford University
Umeå University
Santa Fe Institute